尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2020-12-01
Overseas Regulatory Announcement
2020-11-19
Proposed Election of Directors and Supervisors
2020-11-19
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2020-11-02
Overseas Regulatory Announcement
2020-10-30
Unaudited Quarterly Results Announcement For The Nine Months Ended 30 September
2020-10-22
Overseas Regulatory Announcement
2020-10-22
Continuing Connected Transaction In Relation To Supplemental Trademark Licence A
2020-10-22
Proposed Amendments to The Terms Of Share Option Scheme
2020-10-22
Announcement Notice of Board Meeting
2020-10-12
<
...
34
35
36
37
38
39
40
...
>